Literature DB >> 2878015

Drugs in exacerbation of psoriasis.

E A Abel, L M DiCicco, E K Orenberg, J E Fraki, E M Farber.   

Abstract

Drugs that have been associated with the precipitation or exacerbation of psoriasis include lithium, beta adrenergic receptor blocking agents, and antimalarials. The withdrawal of corticosteroids has been reported to activate pustular psoriasis. Nonsteroidal anti-inflammatory drugs, such as indomethacin, have recently been reported to exacerbate psoriasis, although additional well-controlled studies are still needed. Drugs used for treatment of psoriasis will sometimes cause a flare because of irritation, phototoxicity, or hypersensitivity reaction resulting in a Koebner phenomenon. Because psoriasis is a very complex disease and its activity is often unpredictable, clinical studies on adverse drug effects on psoriasis have been difficult to conduct. This review evaluates clinical, histologic, and biochemical evidence in the literature for drug-associated onset or exacerbation of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878015     DOI: 10.1016/s0190-9622(86)70265-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  26 in total

1.  Histological changes induced by application of lithium carbonate to mouse ear skin.

Authors:  X R Lin; T Huang; C M Yang
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

3.  [Psychosocial factors in psoriasis. A pilot study].

Authors:  J A Bahmer; F Petermann; J Kuhl
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

4.  A case of psoriasis worsened by atorvastatin.

Authors:  Emanuele Cozzani; Manuela Scaparro; Aurora Parodi
Journal:  J Dermatol Case Rep       Date:  2009-12-30

5.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.

Authors:  K Asadullah; W Sterry; K Stephanek; D Jasulaitis; M Leupold; H Audring; H D Volk; W D Döcke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

6.  Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

Authors:  P Panina-Bordignon; D Mazzeo; P D Lucia; D D'Ambrosio; R Lang; L Fabbri; C Self; F Sinigaglia
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

Review 8.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

9.  Lithium and psoriasis: what primary care and family physicians should know.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 10.  Progress in understanding the immunopathogenesis of psoriasis.

Authors:  R K H Mak; C Hundhausen; F O Nestle
Journal:  Actas Dermosifiliogr       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.